Key terms
About TARO
Taro Pharmaceutical Industries Ltd. engages in the development, manufacturing and marketing of prescribed and over-the-counter pharmaceutical products in the U.S., Canada and Israel. Its products include semi-solids formulations, such as creams and ointments and other dosage forms such as liquids, capsules and tablets, in the dermatological and topical, cardiovascular, neuropsychiatric and anti-inflammatory therapeutic categories. The company was founded in 1950 and is headquartered in Haifa Bay, Israel.
Sector
Industry
Employees
Founded
Website
Key stock statistics
1-day range
52-week range
Market cap
P/E ratio
Next earnings date
Dividend yield
Ex-dividend date
Dividend pay date
Key terms
Ad Feedback
Smart score
Latest TARO news
Mar 06
9:20am ET
Lab says chemical linked to cancer found in acne creams, Bloomberg reports
Jan 30
7:08am ET
Taro Pharmaceutical shareholder Krensavage states opposition to takeover bid
Jan 25
5:07pm ET
Taro Pharmaceutical reports Q3 EPS 54c vs. 19c last year
Jan 18
6:11am ET
Taro Pharmaceutical downgraded to Neutral from Buy at H.C. Wainwright
Dec 12
9:47am ET
Taro Pharmaceutical rises 7.6%
Dec 12
6:37am ET
Taro Pharmaceutical (TARO) Receives a Buy from H.C. Wainwright
No recent news articles are available for TARO
No recent press releases are available for TARO
TARO Financials
Key terms
Ad Feedback
TARO Forecasts
analyst rating
- buy
- hold
- sell
1-year stock price forecast
TARO Competitors
$ Market cap
P/E ratio
$ Price
1d change
52-week range
